VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $649,000 | -39.1% | 3,640 | -24.2% | 0.06% | -4.8% |
| Q2 2015 | $1,066,000 | +3.2% | 4,800 | -7.7% | 0.06% | -6.0% |
| Q1 2015 | $1,033,000 | +55.6% | 5,200 | +12.1% | 0.07% | +52.3% |
| Q4 2014 | $664,000 | +4.7% | 4,640 | -3.9% | 0.04% | 0.0% |
| Q3 2014 | $634,000 | -48.7% | 4,830 | -50.7% | 0.04% | -48.2% |
| Q2 2014 | $1,235,000 | -88.8% | 9,795 | -88.3% | 0.08% | -89.5% |
| Q1 2014 | $11,075,000 | -4.1% | 84,011 | -14.6% | 0.81% | -5.8% |
| Q4 2013 | $11,549,000 | +22.0% | 98,376 | +8.4% | 0.86% | +10.7% |
| Q3 2013 | $9,465,000 | -9.3% | 90,726 | -25.2% | 0.78% | -15.7% |
| Q2 2013 | $10,439,000 | – | 121,276 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |